Monte Rosa Therapeutics Inc

NASDAQ:GLUE   2:52:50 PM EDT
33.28
+0.90 (+2.78%)
Earnings Announcements

Monte Rosa Therapeutics Reports Second Quarter 2021 Financial Results And Highlights Pipeline And Business Progress

Published: 08/12/2021 11:47 GMT
Monte Rosa Therapeutics Inc (GLUE) - Monte Rosa Therapeutics Reports Second Quarter 2021 Financial Results and Highlights Pipeline and Business Progress.
Monte Rosa Therapeutics Inc Quarterly Loss per Share $3.63.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.43

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.48

More details on our Analysts Page.